Adherence to anticoagulation: an ongoing challenge
- PMID: 31754932
- PMCID: PMC6890916
- DOI: 10.1007/s12471-019-01347-3
Adherence to anticoagulation: an ongoing challenge
Conflict of interest statement
M.E.W. Hemels has received speaker fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo and Pfizer, and has received a research grant from the Netherlands Federation of Anticoagulation Clinics. J. Seelig receives funding from the Netherlands Federation of Anticoagulation Clinics.
References
-
- Antwoorden op de vragen van de Kamerleden Leijten (SP) en Van Gerven (SP) over het uitblijven van onderzoek naar effectiviteit en veiligheid van nieuwe antistollingsmiddelen: Rijksoverheid; 2015. https://www.rijksoverheid.nl/binaries/rijksoverheid/documenten/kamerstuk.... Accessed 29 Oct 2019.
-
- van Beek H. Nooit meer bloed prikken. Trouw. 5. October. 2012. Front page.
-
- Coleman CI, Briere JB, Fauchier L, et al. Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation. J Mark Access Health Policy. 2019;7(1):1574541. doi: 10.1080/20016689.2019.1574541. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
